The Brain Mapping Research Group (GICC) is located in the Pluridisciplinary Institute of the Complutense University of Madrid and has an uninterrupted trajectory in the field of neurosciences (www.ucace.com). Since 2006 it has formed part of the Network of Laboratories of the Community of Madrid (Lab 194), providing knowledge, equipment, and experience in the study of brain function using EEG evoked potentials in humans and functional imaging by microPET in animals.
At present, the IPCC is composed of ten researchers. Six of them are doctors, belonging to the UCM Faculties of Medicine, Pharmacy and Psychology, all with extensive experience in the field of Biomedicine. The IPCC is completed by a Miguel Servet contract researcher at the IdISSC, two pre-doctoral researchers and a technician specialised in preclinical PET imaging.
Professor Pozo is Professor of Physiology at the Faculty of Medicine of the Complutense University of Madrid and Head of the Brain Mapping Unit of the Pluridisciplinary Institute. Dr. Pozo leads the PET imaging research group of the R&D Activities Programme among the research groups in Biomedicine of the Community of Madrid (MULTIMAG 2006, I2M2 2011 and MULTITARGET & VIEW 2018-22). He is also scientific advisor to Curium Pharma Spain (formerly, Instituto Tecnológico PET), a company dedicated to the production of PET radiopharmaceuticals, advising on the management of R&D&I projects through UCM-Company contracts (Art. 83. LOU). Dr. Pozo has participated in more than 40 projects financed by national and international public funds (MEC, DGICYT, CICYT, FIS, CAM, EU) and has published more than 110 scientific articles in indexed journals. (https://orcid.org/0000-0001-9303-0513). The main line of research is the study of molecular imaging by means of PET in experimental animal models with the translational objective of its clinical utility in the field of neurodegenerative diseases, as well as in epileptogenesis and brain damage. The project is currently being developed under the title: Implication of glial reactivity in epileptogenesis by longitudinal PET-MRI neuroimaging studies (Retos PID2019-106968RB-100).
